Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 1
2007 4
2008 1
2009 1
2010 2
2011 5
2012 4
2013 5
2014 6
2015 8
2016 7
2017 10
2018 7
2019 6
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities.
Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, Füllgrabe J, Jackson A, Jimenez Sanchez M, Karabiyik C, Licitra F, Lopez Ramirez A, Pavel M, Puri C, Renna M, Ricketts T, Schlotawa L, Vicinanza M, Won H, Zhu Y, Skidmore J, Rubinsztein DC. Menzies FM, et al. Among authors: Andrews SP. Neuron. 2017 Mar 8;93(5):1015-1034. doi: 10.1016/j.neuron.2017.01.022. Neuron. 2017. PMID: 28279350 Free article. Review.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. James ND, et al. Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Crystal structure of the GLP-1 receptor bound to a peptide agonist.
Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A, Mason JS, Baig AH, Teobald I, Doré AS, Weir M, Cooke RM, Marshall FH. Jazayeri A, et al. Among authors: Andrews SP. Nature. 2017 Jun 8;546(7657):254-258. doi: 10.1038/nature22800. Epub 2017 May 31. Nature. 2017. PMID: 28562585
USP <800>
Andrews SR, Dill JL. Andrews SR, et al. Hosp Pharm. 2018 Jun;53(3):132-133. doi: 10.1177/0018578718763850. Epub 2018 Mar 7. Hosp Pharm. 2018. PMID: 30147129 Free PMC article. No abstract available.
Small Molecule CXCR3 Antagonists.
Andrews SP, Cox RJ. Andrews SP, et al. J Med Chem. 2016 Apr 14;59(7):2894-917. doi: 10.1021/acs.jmedchem.5b01337. Epub 2015 Nov 4. J Med Chem. 2016. PMID: 26535614 Review.
Current concepts on structure-function relationships in the menisci.
Andrews SHJ, Adesida AB, Abusara Z, Shrive NG. Andrews SHJ, et al. Connect Tissue Res. 2017 May-Jul;58(3-4):271-281. doi: 10.1080/03008207.2017.1303489. Epub 2017 Mar 7. Connect Tissue Res. 2017. PMID: 28267400 Review.
Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists.
Jazayeri A, Andrews SP, Marshall FH. Jazayeri A, et al. Among authors: Andrews SP. Chem Rev. 2017 Jan 11;117(1):21-37. doi: 10.1021/acs.chemrev.6b00119. Epub 2016 Jun 22. Chem Rev. 2017. PMID: 27333206 Review.
Eruptive xanthomas: A collaborative approach using tele-dermatology.
Andrews S, Byrom L, Adikari C, Strungs I, Muir J. Andrews S, et al. Aust Fam Physician. 2016 Jan-Feb;45(1):57-8. Aust Fam Physician. 2016. PMID: 27051990 Free article. No abstract available.
Extra-helical binding site of a glucagon receptor antagonist.
Jazayeri A, Doré AS, Lamb D, Krishnamurthy H, Southall SM, Baig AH, Bortolato A, Koglin M, Robertson NJ, Errey JC, Andrews SP, Teobald I, Brown AJ, Cooke RM, Weir M, Marshall FH. Jazayeri A, et al. Among authors: Andrews SP. Nature. 2016 May 12;533(7602):274-7. doi: 10.1038/nature17414. Epub 2016 Apr 25. Nature. 2016. PMID: 27111510
63 results
Jump to page